INDIMIX

WIPO WIPO 2022

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark INDIMIX was filed as Word mark on 06/21/2022 at the World Intellectual Property Organization.

Trademark Details Last update: July 26, 2023

Trademark form Word mark
File reference 1685037
Register number 018627169
Countries Australia Brazil Canada China United Kingdom Japan South Korea Mexico Philippines Singapore Thailand United States of America (USA)
Base trademark EU No. 018627169, May 11, 2022
Application date June 21, 2022
Expiration date June 21, 2032

Trademark owner

Deutscher Platz 5b
04103 Leipzig
DE

Trademark representatives

Fasanenstr. 29 10719 Berlin DE

goods and services

01 Chemical, biochemical and biotechnological reagents and substances for industrial and scientific purposes and laboratory analysis, other than in vivo use; biochemicals for scientific and research use, namely, for sample preparation, modification and manipulation of cells and for labeling, isolation, purification, amplification and analysis of natural and synthetic biopolymers, namely, nucleotides, buffer substances such as salts, proteins, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; biochemicals, namely, small molecular chemicals for scientific or research use; laboratory chemicals, namely, small molecular chemicals used for the detection of nucleic acids in cell and tissue analysis for in vitro diagnostic use; chemicals and biochemical preparations used in industry, in particular, chemical and biochemical substances for molecular biological, biochemical and immunological laboratory testing and analysis, other than for medical or veterinary purposes; kits comprising biochemical reagents for scientific and research use, namely, for sample preparation, modification and manipulation of samples and cells and for labeling, separation, isolation, purification, especially amplification and analysis of natural and synthetic biopolymers, in particular, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances, none of the foregoing for medical or veterinary use; kits for multiplex polymerase chain reaction (PCR) tests comprised of DNA primers for amplifying DNA and RNA loci
05 Pharmaceutical medical products for treating infections; veterinary medical products, namely, vaccines; medical products for medical healthcare purposes, namely, reagents; diagnostic preparations for medical and veterinary purposes; diagnostic agents for medical and veterinary purposes, namely, diagnostic agents for medical and veterinary in-vitro diagnostics; diagnostic agents for medical and veterinary purposes, namely, biological diagnostic agents for testing diseases in cattle, pigs, and other animals; kits comprised of reagents, oligonucleotides, antibodies, in-vitro diagnostic reagents and control reagents all for medical purposes, sold as a unit for medical purposes; diagnostic test kits comprised of testing equipment in the nature of biomolecules, namely, oligonucleotides, primers and probes for DNA and RNA biomarker testing and DNA and RNA infectious disease testing for medical, veterinary, and dental purposes; products for medical and veterinary medical purposes, namely, diagnostic preparations for sample preparation, modification and manipulation of cells and for labelling, separation, isolation, purification, amplification and analysis of natural and synthetic biopolymers, namely, nucleic acids, oligonucleotides, proteins, macromolecules and biologically active substances; chemical, biochemical and biotechnological products, namely, reagents for medical use, namely, for sample preparation, modification and manipulation of cells, all for medical use; in vitro diagnostic preparations for medical purposes; diagnostic disease testing kits comprised of medical diagnostic reagents, buffers for medical and veterinary purposes; diagnostic disease testing kits comprised of reagents, oligonucleotides, nucleotides, buffers, in-vitro diagnostic preparations, and control reagents all for medical and veterinary use, sold as a unit for medical and veterinary use

Trademark history

Date Document number Area Entry
July 13, 2023 2023/28 Gaz JP Rejection
July 12, 2023 2023/28 Gaz BR Rejection
June 6, 2023 2023/23 Gaz US Rejection
May 10, 2023 2023/23 Gaz SG Rejection
March 7, 2023 2023/10 Gaz CN Rejection
December 21, 2022 2022/51 Gaz GB Rejection
December 7, 2022 2022/49 Gaz AU Rejection
October 18, 2022 2022/42 Gaz PH Rejection
June 21, 2022 2022/36 Gaz EM Registration

ID: 141685037